These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3893732)

  • 41. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
    Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
    Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure of 8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dichlorobenzoate methylsulfate monohydrate (MDL 72222), an antagonist at neuronal 5-HT receptors.
    Carpy A; Lemrabett A; Colleter JC
    Acta Crystallogr C; 1988 Mar; 44 ( Pt 3)():495-7. PubMed ID: 3271069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study.
    Kellstein DE; Lipton RB; Geetha R; Koronkiewicz K; Evans FT; Stewart WF; Wilkes K; Furey SA; Subramanian T; Cooper SA
    Cephalalgia; 2000 May; 20(4):233-43. PubMed ID: 10999673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A review of the pharmacologic treatment of migraine in children].
    Vasconcellos E
    Rev Neurol; 2003 Aug 1-15; 37(3):253-9. PubMed ID: 12938057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of 5-HT(3) receptor with MDL 72222 and Y 25130 reduces beta-amyloid protein (25--35)-induced neurotoxicity in cultured rat cortical neurons.
    Ju Yeon Ban ; Yeon Hee Seong
    Eur J Pharmacol; 2005 Sep; 520(1-3):12-21. PubMed ID: 16150439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
    J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache.
    Couturier EG; Hering R; Foster CA; Steiner TJ; Clifford Rose F
    Headache; 1991 May; 31(5):296-7. PubMed ID: 1650335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine.
    Kangasniemi PJ; Nyrke T; Lang AH; Petersen E
    Acta Neurol Scand; 1983 Oct; 68(4):262-7. PubMed ID: 6606930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin S2 receptors and migraine: a study with the selective antagonist ICI 169,369.
    Davies PT; Steiner TJ
    Headache; 1990 May; 30(6):340-3. PubMed ID: 2370133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of intravenous verapamil on acute migraine headache.
    Molaie M; Olson CM; Koch J
    Headache; 1987 Jan; 27(1):51-3. PubMed ID: 3549629
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of tyramine in migraine: a double-blind study.
    Moffett A; Swash M; Scott DF
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):496-9. PubMed ID: 4559027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?
    Terrón JA
    Eur J Pharmacol; 2002 Mar; 439(1-3):1-11. PubMed ID: 11937086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vigabatrin. GVG, MDL 71754, RMI 71754, Sabril, Sabrilex, gamma-vinyl-GABA.
    Drugs R D; 1999 Dec; 2(6):393-6. PubMed ID: 10763450
    [No Abstract]   [Full Text] [Related]  

  • 58. Fenoprofen in the prophylaxis of migraine: a double-blind, placebo controlled study.
    Diamond S; Solomon GD; Freitag FG; Mehta ND
    Headache; 1987 May; 27(5):246-9. PubMed ID: 3298164
    [No Abstract]   [Full Text] [Related]  

  • 59. A double-blind controlled study of seratonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients.
    Johansson F; Von Knorring L
    Pain; 1979 Aug; 7(1):69-78. PubMed ID: 388295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous Zofran for headache.
    Gruppo LQ
    J Emerg Med; 2006 Aug; 31(2):228-9. PubMed ID: 17044590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.